Personalizing the decision of dabigatran versus warfarin in atrial fibrillation: A secondary analysis of the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) trial.
Samuel W ReinhardtNihar R DesaiYuanyuan TangPhilip G JonesJeremy AderJohn A SpertusPublished in: PloS one (2021)
www.clinicaltrials.gov number, NCT00262600.